DANVILLE REGIONAL MEDICAL CENTER — History
CCN 490075 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$352M
Latest Revenue (FY2022)
+1.7%
Revenue CAGR (3yr)
6.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $340M | $371M | $352M | -5.2% | +1.7% |
| Operating Expenses | $314M | $330M | $328M | -0.6% | +2.2% |
| Operating Margin | 7.7% | 11.2% | 6.8% | -38.6% | -5.7% |
| Net Income | $26M | $41M | $24M | -41.8% | -4.1% |
| Licensed Beds | 283 | 272 | 232 | -14.7% | -9.5% |
| Total Patient Days | 52,466 | 49,167 | 39,900 | -18.8% | -12.8% |
| Medicare Day % | 40% | 35% | 29% | -17.2% | -15.3% |
| Medicaid Day % | 2% | 3% | 2% | -18.4% | -3.0% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +3.5% ($340M → $352M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.7%
This Hospital
+7.6%
State Avg
Latest Margin
6.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $358M | 6.4% |
| FY2024 (proj) | $364M | 6.0% |
| FY2025 (proj) | $370M | 5.6% |